Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01091558 · ClinicalTrials.gov registry record
Study of Effects of L-Arginine in Colitis and Colon Cancer
A clinical trial, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- 204
- Enrollment target
NCT01091558 is a clinical trial that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 204 participants.
The verdict
NCT01091558 has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- 204 participants
- Enrollment target
Study Summary
The purpose of this study is to look at the importance of L-Arginine in the digestive tract. L-Arginine is an amino acid and is important in making proteins within the cell. The evaluation of colon tissue, blood, urine, diet, health history, and symptoms will help us learn more about L-Arginine and ulcerative colitis. The investigators believe these studies will provide new insights into the treatment for Inflammatory Bowel Disease (ulcerative colitis) and nutritional needs. The investigators plan to enroll 200 participants in this study over the next two years.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 204 participants |
| Start Date | 2009-09 |
| Est. Completion | 2011-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01091558
The ClinicalTrials.gov registry entry for NCT01091558 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 204 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01091558 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01091558 about?
NCT01091558 is a clinical study titled "Study of Effects of L-Arginine in Colitis and Colon Cancer". The purpose of this study is to look at the importance of L-Arginine in the digestive tract. L-Arginine is an amino acid and is important in making proteins within the cell. The evaluation of colon tissue, blood, urine, diet, health history, and symptoms will help us learn more about L-Arginine and...
What is the current status of trial NCT01091558?
This trial is currently completed. The enrollment target is 204 participants. The study started on 2009-09. Estimated completion is 2011-12.
Who is sponsoring clinical trial NCT01091558?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.